SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001520138-15-000038
Filing Date
2015-02-05
Accepted
2015-02-05 14:49:51
Documents
9
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nnab-20141231_10q.htm 10-Q 197413
2 EXHIBIT 31.1 nnab-20141231_10qex31z1.htm EX-31.1 12349
3 EXHIBIT 32.1 nnab-20141231_10qex32z1.htm EX-32.1 5811
  Complete submission text file 0001520138-15-000038.txt   1326753

Data Files

Seq Description Document Type Size
4 XBRL DEFINITION FILE nnab-20141231_def.xml EX-101.DEF 14727
5 XBRL LABEL FILE nnab-20141231_lab.xml EX-101.LAB 95962
6 XBRL PRESENTATION FILE nnab-20141231_pre.xml EX-101.PRE 70329
7 XBRL INSTANCE FILE nnab-20141231.xml EX-101.INS 119639
8 XBRL SCHEMA FILE nnab-20141231.xsd EX-101.SCH 13016
9 XBRL CALCULATION FILE nnab-20141231_cal.xml EX-101.CAL 17127
Mailing Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915
Business Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915 3055154118
NANOANTIBIOTICS, INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-55292 | Film No.: 15579764
SIC: 2834 Pharmaceutical Preparations